S
Sai Parenterals Limited IPO
🟢 Open NowNSE + BSEMainboard IPOHealthcare
Issue Price
₹372–392
Issue Size
₹409 Cr
Lot Size
38 shares
Min. Invest
₹15K
Open Date
24 Mar 2026
Close Date
27 Mar 2026
Allotment
28 Mar 2026
Listing Date
1 Apr 2026
IPOGenie Score — Sai Parenterals Limited
Our 5-factor scoring model: Financial Quality (30) + Subscription (25) + GMP (20) + Business (15) + Risk (10). Total: 34/100 — Avoid.
Financial Quality15/30
Subscription Momentum0/25
GMP Sentiment3/20
Business Quality8/15
Risk Assessment8/10
This score is an analytical tool only, not investment advice. Consult a SEBI-registered advisor.
Live Subscription Status
(Updated 2× daily from BSE+NSE)Subscription data will appear once bidding begins.
Above 1x = oversubscribed. QIB subscription is the strongest institutional conviction signal.
IPOGenie Review — Sai Parenterals Limited
IV fluids (LVP) and injectables (SVP) for hospitals across India. Government supply via National Health Mission provides revenue stability. 150M unit/year capacity. Exports to 8 countries.
Verdict: Neutral. Decent business but expensive at 40x PE for a commodity pharma manufacturer competing with Baxter, Fresenius Kabi, B Braun. Zero GMP signals muted market interest. Apply only with long-term pharma conviction.
Strengths
- Essential medicines — IV fluids are non-discretionary hospital supply
- Government NHM contracts provide revenue stability
- WHO-GMP certification enables exports
Risks
- 40x PE expensive for commodity parenteral segment
- Competition from global MNCs (Baxter, Fresenius, B Braun)
- Zero GMP — weak grey market sentiment
Sai Parenterals Limited IPO — Complete Details
| Open Date | 24 March 2026 |
| Close Date | 27 March 2026 |
| Allotment Date | 28 March 2026 |
| Listing Date | 1 April 2026 |
| Price Band | ₹372 – ₹392 per share |
| Face Value | ₹10 per share |
| Lot Size | 38 shares |
| Min. Investment (Retail) | ₹14,896 |
| Issue Size | ₹409 Crores |
| Fresh Issue | ₹250 Crores |
| Offer for Sale (OFS) | ₹159 Crores |
| Listing Exchange | NSE, BSE |
| IPO Type | Mainboard IPO (NSE + BSE) |
| Issue Type | Book Built |
| Registrar | KFin Technologies Ltd |
| Lead Manager(s) | Equirus Capital Pvt Ltd, JM Financial Ltd |
| Anchor Allocation | ₹122.7 Crores |
| Promoter Holding (Pre-IPO) | 68.4% |
Sai Parenterals Limited — Financial Snapshot
Revenue
₹412 Cr
Net Profit (PAT)
₹42 Cr
EPS (Diluted)
₹9.8
P/E (Post-Issue)
40x
ROE
13.2%
ROCE
15.4%
Market Cap
₹1960 Cr
Sector
Healthcare
Use of IPO Proceeds
- 1Manufacturing expansion: Rs 120 crore
- 2Working capital: Rs 80 crore
- 3General corporate purposes
IPO Documents
⚠️ Always read the RHP before investing — it contains all material risk factors and financial disclosures.
Frequently Asked Questions — Sai Parenterals Limited IPO
When does Sai Parenterals Limited IPO open and close?
Sai Parenterals Limited IPO opens on 24 March 2026 and closes on 27 March 2026. Allotment is expected on 28 March 2026 and listing on 1 April 2026.
What is the price band and lot size of Sai Parenterals Limited IPO?
Sai Parenterals Limited IPO price band is ₹372–₹392 per share. Lot size is 38 shares. Minimum investment for retail investors is ₹14,896 (1 lot at cut-off price).
What is the GMP of Sai Parenterals Limited IPO today?
Sai Parenterals Limited IPO GMP (Grey Market Premium) is currently ₹0, indicating no significant grey market activity. This could mean the market is awaiting more subscription data. GMP is unofficial and not regulated by SEBI.
How to check Sai Parenterals Limited IPO allotment status?
Check Sai Parenterals Limited IPO allotment status on the registrar website — KFin Technologies Ltd (https://kfintech.com). You can also check on BSE (bseindia.com → Investors → Application Status) using your PAN number. Allotment is finalised on 28 March 2026.
Is Sai Parenterals Limited IPO good for investment?
IPOGenie rates Sai Parenterals Limited IPO as "Neutral" with a score of 34/100. Sai Parenterals manufactures large and small volume parenterals — IV fluids, injectables, ophthalmic solutions. Supplies to government hospitals via N... Always read the RHP and consult a SEBI-registered advisor before investing.
How to apply for Sai Parenterals Limited IPO?
Apply for Sai Parenterals Limited IPO through: (1) UPI method — use any broker app (Zerodha, Groww, Upstox) and approve the UPI mandate. (2) ASBA — through your bank's net banking IPO section. Apply at cut-off price for best allotment odds. Maximum retail application is ₹2 lakh (13 lots).
What is the issue size of Sai Parenterals Limited IPO?
Sai Parenterals Limited IPO total issue size is ₹409 Cr. Fresh issue is ₹250 Cr and Offer for Sale (OFS) is ₹159 Cr. Anchor investor allocation was ₹122.7 Cr.